ARCHIVES

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Proteomics Used To Find Predictor Of Response In FAP

April 30, 2004

NCI Budget for FY 1977 Would Halt New Research

January 23, 1976

Tucson Conference Could Be Lively

February 16, 1979

Breast Cancer Treatment Studies Need Standard Definitions – Carbone

May 10, 1974

Kansas City Clinic Settles Medicare Overbilling Claim

June 6, 2014

NCI Offers 200 Cell Lines to Scientist

May 6, 1983